Contact Information: digiMedical Solutions, Inc. Investor Relations ir@digimedical.com 214-722-3029
digiMedical Solutions, Inc. Signs Contract With Advanced Gastroenterology to Implement Microsoft-Based Digital Prescription Technology as Company Continues to Expand Sales in Florida
Contract Follows Multiple Recent Contracts Anticipated to Support Company's 2008 $10 Million Revenue Goal
| Source: digiMedical Solutions, Inc.
COLLEYVILLE, TX--(Marketwire - May 8, 2008) - digiMedical Solutions, Inc. (PINKSHEETS : DGMS ) announced today that the Company has signed a contract with Dr.
Shardul Nanavati, founder of Advanced Gastroenterology of Naples, Florida
(http://naplesgastro.com/home_gastro.shtml). digiMedical will implement the
Company's Microsoft-based digital prescription handling software, digiRX
and digiReauth, and will supply call center services to support the
reauthorization of prescriptions. Dr. Nanavati graduated with honors from
Johns Hopkins University and completed his medical degree at University of
Vermont College of Medicine. Dr. Nanavati, a member of the American
Gastroenterologic Association, American College of Gastroenterology,
American Medical Association and Collier Medical Society, is a digestive
disease specialist.
Multiple Doctors to Implement digiMedical Digital Prescription Software
Each new doctor contract can add hundreds of patients to the digiRX
network, who in turn drive prescription sales into company owned pharmacies
and increase company revenue. digiMedical is actively expanding their
regional footprint in the Naples area in support of the 2008 revenue goal
of $10 million.
This contract follows multiple other recent contracts with doctors in the
area, to include Dr. Moorthy of Pain Management Center of Naples, Dr.
Albert A. Alessi of Alessi Family Care, Drs. Romero, Tineo and Seibert of
Oaktree Family Practice, Orthopedic Surgeon Dr. Howard Kapp of Anchor
Health Centers, Drs. Santos-Ocampo, Axline and Spilker of the Collier Heart
Group, the Medical Director of Vanish Vein and Laser Center and Dr. Wey of
the Neuroscience and Spine Associates in Naples, Florida.
digiMedical Prescription Handling Software and Pharmacies
digiMedical Solutions, a Microsoft Partner, with operations in Texas and
Florida, has built its own suite of proprietary software to handle
prescriptions digitally from the physician's office to the pharmacy,
securely and in compliance with all DEA and HIPAA requirements. The suite
of software includes digiRX, digiRxStream, digiReauth, digiRxComp, and now
digiAccounting and the Company owns and operates five pharmacies throughout
Texas and Florida.
Company Fact Sheet and Updates
To be added to digiMedical's corporate e-mail list for shareholders and
interested investors or to receive a Fact Sheet on the company, please send
an e-mail to ir@digimedical.com.
About digiMedical Solutions, Inc.™
digiMedical Solutions, Inc.™ (www.digimedical.com) is a pharmacy and
medical technology company focused on developing next generation digital
medical technology with an emphasis on digital prescriptions
(d-Prescriptions) that will more closely align the doctor, pharmacist and
patient. The company's planned growth will come from three channels: direct
marketing of the company's wireless base d-prescription technology to
doctors, acquisition of independent pharmacy chains and the sale of certain
territories to "market partners" licensed to exploit the digiMedical
Solutions™ model. digiMedical Solutions, Inc.™ currently owns and
operates five (5) pharmacies located in Texas and Florida. digiMedical
Solutions'™ unique business model brings doctor, patients and pharmacies
into next generation medical technologies.
Forward-Looking Statement
Statements included in this press release which are not historical in
nature, are intended to be, and are hereby identified as ``Forward-Looking
Statements'' for purposes of safe harbor provided by Section 21E of the
Securities Exchange Act of 1934, as amended. Forward Looking Statements may
be identified by words including "anticipate,'' "await,'' "envision,''
"foresee,'' "aim at,'' "believe,'' "intends,'' "estimates'' including
without limitation, those relating to the company's future business
prospects, are subject to certain risks and uncertainties that could cause
actual results to differ materially from those indicated in the
Forward-Looking Statements. Readers are directed to the company's filings
with the U.S. Securities and Exchange Commission for additional information
and a presentation of the risks and uncertainties that may affect the
company's business and results of operations.